{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-105509","form_type":"8-K","ticker":"RANI","cik":"0001856725","company_name":"Rani Therapeutics Holdings, Inc.","filed_at":"2024-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.970768+00:00","generated_at":"2026-05-31T05:29:20.699934+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Rani Therapeutics dismisses EY as auditor, appoints Marcum; EY's 2023 report had going concern doubt","bullets":["EY dismissed as independent auditor on Sep 10, 2024; Marcum LLP appointed immediately.","EY's 2023 audit opinion included a going concern explanatory paragraph about substantial doubt.","No disagreements or reportable events in fiscal 2022, 2023, or subsequent interim period.","Letter from EY to SEC confirming agreement attached as Exhibit 16.1."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-105509","json":"https://secwatch.observer/filing/0000950170-24-105509.json","markdown":"https://secwatch.observer/filing/0000950170-24-105509.md","text":"https://secwatch.observer/filing/0000950170-24-105509.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1856725/000095017024105509/0000950170-24-105509-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1856725/000095017024105509/rani-20240910.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:29:20.699934+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}